Top Markets
Coin of the day
Lite Strategy, Inc. Lite Strategy, Inc.

Lite Strategy, Inc.

LITS
Rangering i aksjer #27541
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Aksjekurs
$0.9474
Sist synkronisert: 2026-08-19
Markedsverdi
$32.24M
Endring (1 dag)
7.41%
Endring (1 år)
-
Land
US
Handel Lite Strategy, Inc. (LITS)

Kategori

Utbytteavkastning for Lite Strategy, Inc. (LITS)
Lite Strategy, Inc. (aksjesymbol: LITS) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Lite Strategy, Inc. (LITS) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH